Generated $459 million in 3Q 2025 revenues, including $178 million in U.S. net product salesReceived 152 new patient start forms for EMPAVELI® ...

For biopharma, reaching the right patients at the right time is essential for both clinical and commercial success. The right ...

While recent fertility drug-related announcements by the Trump administration could result in savings for women—especially ...

Boston When they first walk into Match Charter Public High School, students confront a purely physical challenge: its steep ...

Once-daily, effective, safe, and well-tolerated ZORYVE cream 0.05% now commercially available for children as young as age 2ZORYVE cream 0.05% ...

Higher prices, less help and a government shutdown all hang over health insurance markets as shoppers start looking for ...

Fire departments that are struggling with staffing issues can benefit from the efforts of the Detroit Fire Department in ...

President Trump’s sweeping legislation is bringing dramatic changes to Medicaid, SNAP, and other government programs — and ...

Good morning, and welcome to Ionis Third Quarter 2025 Financial Results Conference Call. As a reminder, this call is being recorded. At this time, I would like to turn the conference over to Mr. Wade ...

Q3 2025 Earnings Call Transcript October 28, 2025 Regeneron Pharmaceuticals, Inc. beats earnings expectations. Reported EPS ...

Rural hospitals and clinics nationwide face a looming financial catastrophe, with President Donald Trump’s massive ...

RESEDA, CA – October 23, 2025 – PRESSADVANTAGE – Moment of Clarity has released a new resource titled “What to Know About TMS ...